UCSF Helen Diller Family Comprehensive Cancer Ctr (@ucsfcancer) 's Twitter Profile
UCSF Helen Diller Family Comprehensive Cancer Ctr

@ucsfcancer

Championing basic science, clinical research, epidemiology/cancer control, and patient care.
Contact: [email protected]

ID: 381154948

linkhttps://cancer.ucsf.edu calendar_today27-09-2011 20:53:39

14,14K Tweet

9,9K Followers

2,2K Following

UCSF Helen Diller Family Comprehensive Cancer Ctr (@ucsfcancer) 's Twitter Profile Photo

Tuesday, April 29th 10:45 AM CT | UC San Francisco at #AACR25 | Major Symposium: Immunology with Hideho Okada, MD, PhD presenting "Tumor-wide RNA splicing aberrations generate therapeutically actionable public neoantigens" at ow.ly/LgEG50VJjWP @aacr

Tuesday, April 29th 10:45 AM CT |  <a href="/UCSF/">UC San Francisco</a> at #AACR25 | Major Symposium: Immunology with
 Hideho Okada, MD, PhD presenting "Tumor-wide RNA splicing aberrations generate therapeutically actionable public neoantigens" at ow.ly/LgEG50VJjWP @aacr
UCSF Health (@ucsfhospitals) 's Twitter Profile Photo

UCSF neurosurgery experts including Drs. Shawn Shawn Hervey-Jumper, Rob Osorio, Praveen Mummaneni & Dr. Nima Alan presented new research & clinical findings at the prestigious AANS Annual Scientific Meeting in Boston. #AANS2025 Details on their talks ➡️ ucsfh.org/3YjF3UW

UCSF neurosurgery experts including Drs. Shawn <a href="/HerveyJumper/">Shawn Hervey-Jumper</a>, <a href="/robcosorio/">Rob Osorio</a>, Praveen Mummaneni &amp; Dr. Nima Alan presented new research &amp; clinical findings at the prestigious <a href="/AANSNeuro/">AANS</a> Annual Scientific Meeting in Boston. #AANS2025 Details on their talks ➡️ ucsfh.org/3YjF3UW
Tadashi Manabe MD, PhD (@tadashi_manabe) 's Twitter Profile Photo

Excited to present my research on Exarafenib at #AACR25 tomorrow. My work demonstrates promising efficacy against all classes of BRAF mutations in NSCLC, especially Class 2/3 that lack treatment options. #CancerResearch #BRAF #LungCancer

Carissa Chu (@cchumd) 's Twitter Profile Photo

Check out our podium at #AUA25 tomorrow discussing upstream regulators of STEAP1 in prostate cancer, presented by Dr. Sasha Zhu UCSFUrology UCSF Helen Diller Family Comprehensive Cancer Ctr auajournals.org/doi/10.1097/01…

Check out our podium at #AUA25 tomorrow discussing upstream regulators of STEAP1 in prostate cancer, presented by Dr. Sasha Zhu

<a href="/UCSFUrology/">UCSFUrology</a> <a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a> 

 auajournals.org/doi/10.1097/01…
Ben Huang (@benhuanglab) 's Twitter Profile Photo

Excited to share that our work was published in Journal of Clinical Oncology! A report from the Children’s Oncology Group: stem cell transplantation is associated with improved outcomes for children diagnosed with high-risk acute myeloid leukemia (AML). ascopubs.org/doi/10.1200/JC…

Klebanoff_Lab (@klebanofflab) 's Twitter Profile Photo

🚨🧬Everything you wanted to know about actionable #neoantigens resulting from cancer mutations besides point mutations (*but were afraid to ask). Join us at 10:15 in 📍Room E351 - McCormick Lakeside Center (Level 3)! Memorial Sloan Kettering Cancer Center UCSF Helen Diller Family Comprehensive Cancer Ctr Institut Curie

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

At the #AACR25 plenary, Matthew Krummel, PhD, (UCSF Helen Diller Family Comprehensive Cancer Ctr) explores therapeutic strategies to reshape the tumor micro- and macroenvironment, including 12 tumor immune archetypes that may help uncover novel targeted treatments. Read more: abstractsonline.com/pp8/#!/20273/p… #MoffittAACR25

At the #AACR25 plenary, Matthew Krummel, PhD, (<a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a>) explores therapeutic strategies to reshape the tumor micro- and macroenvironment, including 12 tumor immune archetypes that may help uncover novel targeted treatments.

Read more: abstractsonline.com/pp8/#!/20273/p…
#MoffittAACR25
Yu-Ting (@ytchou) 's Twitter Profile Photo

Catch the Bivona Lab team at #AACR25 on April 29th! Tadashi Manabe MD, PhD | 2:30–4:00 PM Minisymposium, Room S102 Yu-Ting | 2:00–5:00 PM Section 18, Board 19 Nilanjana Chatterjee | 2:00–5:00 PM Section 17, Board 5 We’ll be sharing our latest research UCSF Helen Diller Family Comprehensive Cancer Ctr

Catch the <a href="/BivonaLabUCSF/">Bivona Lab</a> team at #AACR25 on April 29th!

<a href="/Tadashi_Manabe/">Tadashi Manabe MD, PhD</a> | 2:30–4:00 PM
Minisymposium, Room S102

<a href="/YTChou/">Yu-Ting</a> | 2:00–5:00 PM
Section 18, Board 19

Nilanjana Chatterjee | 2:00–5:00 PM
Section 17, Board 5

We’ll be sharing our latest research <a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a>
UCSF Helen Diller Family Comprehensive Cancer Ctr (@ucsfcancer) 's Twitter Profile Photo

Tues, April 30th 10:15 AM CT | UC San Francisco at #AACR25 | Xiaokun Shu, PhD, presents "New physical biology of oncoprotein condensates: Differential regulation of the transcriptome by phase separation" at @aacr. Session preview: ow.ly/wqrQ50VJkuC

Tues, April 30th 10:15 AM CT |  <a href="/UCSF/">UC San Francisco</a> at #AACR25  | Xiaokun Shu, PhD, presents "New physical biology of oncoprotein condensates: Differential regulation of the transcriptome by phase separation" at @aacr. Session preview: ow.ly/wqrQ50VJkuC
UCSF Helen Diller Family Comprehensive Cancer Ctr (@ucsfcancer) 's Twitter Profile Photo

Friday, May 1st at 4pm: Maria Castro, PhD maria g castro @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our UC San Francisco Friday Seminar Series in Basic and Translational Research ow.ly/L7CP50VJkUw

Friday, May 1st at 4pm: Maria Castro, PhD <a href="/castro2355_mg/">maria g castro</a> @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our <a href="/UCSF/">UC San Francisco</a> Friday Seminar Series in Basic and Translational Research ow.ly/L7CP50VJkUw
Tadashi Manabe MD, PhD (@tadashi_manabe) 's Twitter Profile Photo

Successfully presented my research on Exarafenib at #AACR25 today. Grateful to the session chairs for their valuable feedback and support. Looking forward to the future of BRAF-targeted therapies in cancer! #CancerResearch #LungCancer #BRAF

Successfully presented my research on Exarafenib at #AACR25 today. Grateful to the session chairs for their valuable feedback and support. Looking forward to the future of BRAF-targeted therapies in cancer! #CancerResearch #LungCancer #BRAF
AACR (@aacr) 's Twitter Profile Photo

We thank the more than 22,000 attendees—including more than 900 virtual attendees—from 81 countries who participated in the AACR Annual Meeting 2025 in Chicago. The #AACR25 hashtag garnered 636 million impressions from 3,852 users on X alone.

We thank the more than 22,000 attendees—including more than 900 virtual attendees—from 81 countries who participated in the AACR Annual Meeting 2025 in Chicago. The #AACR25 hashtag garnered 636 million impressions from 3,852 users on X alone.
UCSF Helen Diller Family Comprehensive Cancer Ctr (@ucsfcancer) 's Twitter Profile Photo

Donʻt miss today, May 1st at 4pm: Maria Castro, PhD maria g castro @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our Friday Seminar Series UC San Francisco ow.ly/6jh650VJkV5

Donʻt miss today, May 1st at 4pm: Maria Castro, PhD <a href="/castro2355_mg/">maria g castro</a> @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our Friday Seminar Series <a href="/UCSF/">UC San Francisco</a>  ow.ly/6jh650VJkV5
AACR (@aacr) 's Twitter Profile Photo

The overall cancer death rate is declining steadily in the US, and more individuals are living longer and fuller lives after a cancer diagnosis. Read about the research-driven progress during National Cancer Research Month—#NCRM25: brnw.ch/21wSpgz #UnitedByCancerResearch

The overall cancer death rate is declining steadily in the US, and more individuals are living longer and fuller lives after a cancer diagnosis. Read about the research-driven progress during National Cancer Research Month—#NCRM25: brnw.ch/21wSpgz #UnitedByCancerResearch
AACR (@aacr) 's Twitter Profile Photo

May is National Cancer Research Month. Dr. LoRusso, AACR Past President, explains how basic research is essential to accelerating advances in cancer science and medicine. Learn more in the AACR Cancer Progress Report: brnw.ch/21wSpYt #NCRM25 #UnitedByCancerResaerch

UCSF Helen Diller Family Comprehensive Cancer Ctr (@ucsfcancer) 's Twitter Profile Photo

“The field as a whole, in the last 10 years, has gone incredibly fast to come up with innovative molecules to target KRAS” Kevan Shokat UC San Francisco in #AACR25 Keynote | Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR ow.ly/UBT250VN3Z9 @aacr

“The field as a whole, in the last 10 years, has gone incredibly fast to come up with innovative molecules to target KRAS” <a href="/kevansf/">Kevan Shokat</a> <a href="/UCSF/">UC San Francisco</a> in #AACR25 Keynote | Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR ow.ly/UBT250VN3Z9 @aacr